References
- Johansson SA, Andersson KE, Brattsand R, et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol. 1982;22:523–529. Available from https://doi.org/10.1007/BF00609625
- Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142:832–836.
- Spencer CM, McTavish D. Budesonide. Drugs. 1995;50:854–872.
- Donnelly R, Seale JP. Clinical pharmacokinetics of inhaled budesonide. Clin Pharmacokinet. 2001;40:427–440.
- Dalby C, Polanowski T, Larsson T, et al. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. Respir Res. 2009;10:104–115.
- Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today. 2012;17:486–495.
- Zhou L, Yang L, Tilton S, et al. Development of a high throughput equilibrium solubility assay using miniaturized shake‐flask method in early drug discovery. Drug Discov Today. 2007;96:3052–3071.
- Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv Drug Delivery Rev. 2007;59:546–567.
- Mota FL, Carneiro AP, Queimada AJ, et al. Temperature and solvent effects in the solubility of some pharmaceutical compounds: measurements and modeling. Eur J Pharm Sci. 2009;37:499–507.
- Ali HSM, York P, Blagden N, et al. Solubility of budesonide, hydrocortisone, and prednisolone in ethanol + water mixtures at 298.2 K. J Chem Eng Data. 2009;55:578–582.
- Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21:201–230.
- Jouyban A, Fakhree MAA, Shayanfar A. Review of pharmaceutical applications of N-methyl-2-pyrrolidone. J Pharm Pharm Sci. 2010;13:524–535.
- Lee PJ, Langer R, Shastri VP. Role of N‐methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci. 2005;94:912–917.
- Uch AS, Hesse U, Dressman JB. Use of 1-methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs. Pharm Res. 1999;16:968–971.
- Ishihara T, Goto M, Kanazawa H, et al. Efficient entrapment of poorly water‐soluble pharmaceuticals in hybrid nanoparticles. J Pharm Sci. 2009;98:2357–2363.
- Koizumi A, Fujii M, Kondoh M, et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm. 2004;57:473–478.
- Jouyban A. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. J Pharm Pharm Sci. 2008;11:32−58.
- Jouyban-Gharamaleki A, Valaee L, Barzegar-Jalali M, et al. Comparison of various cosolvency models for calculating solute solubility in water–cosolvent mixtures. Int J Pharm. 1999;177:93–101.
- Jouyban A, Fakhree MAA. Toxicity and drug testing. In: Acree Jr WE, editor. Intech co. Chap. 9. New York (NY): Intech co.; 2012.
- Delgado DR, Rodríguez GA, Martínez F. Thermodynamic study of the solubility of sulfapyridine in some ethanol + water mixtures. J Mol Liq. 2013;177:156–161.
- Vahdati S, Shayanfar A, Hanaee J, et al. Solubility of carvedilol in ethanol + propylene glycol mixtures at various temperatures. Ind Eng Chem Res. 2013;52:16630–16636.
- Jouyban-Gharamaleki A, Acree WE Jr. Comparison of models for describing multiple peaks in solubility profile. Int J Pharm. 1998;167:177–182.
- Jouyban A, Khoubnasabjafari M, Chan HK, et al. Mathematical representation of solubility of amino acids in binary aqueous-organic solvent mixtures at various temperatures using Jouyban-Acree model. Pharmazie. 2006;61:789–792.
- Jouyban A, Acree WE Jr. In silico prediction of drug solubility in water-ethanol mixtures using Jouyban-Acree model. J Pharm Pharm Sci. 2006;9:262–269.
- Jouyban-Gharamaleki A. The modified Wilson model and predicting drug solubility in water-cosolvent mixtures. Chem Pharm Bull. 1998;46:1058–1061.
- Shayanfar A, Fakhree MAA, Acree WE Jr, et al. Solubility of lamotrigine, diazepam, and clonazepam in ethanol + water mixtures at 298.15 K. J Chem Eng Data. 2008;54:1107–1109.
- Soltanpour S, Jouyban A. Solubility of acetaminophen and ibuprofen in polyethylene glycol 600, N-methyl pyrrolidone and water mixtures. J Solution Chem. 2011;40:2032–2045.
- Eghrary SH, Zarghami R, Martinez F, et al. Solubility of 2-butyl-3-benzofuranyl 4-(2-(diethylamino) ethoxy)-3, 5-diiodophenyl ketone hydrochloride (amiodarone HCl) in ethanol + water and N-methyl-2-pyrrolidone + water mixtures at various temperatures. J Chem Eng Data. 2012;57:1544–1550.
- Soltanpour S, Jafari B, Barzegar-Jalali M, et al. Solubility of glibenclamide in the aqueous mixtures of polyethylene glycol 400, propylene glycol and N-methyl-pyrrolidone at 298.2 K. J Drug Deliv Sci Technol. 2014;24:111–115.
- Sanghvi R, Narazaki R, Machatha SG, et al. Solubility improvement of drugs using N-methyl pyrrolidone. Aaps Pharmscitech. 2008;9:366–376.
- Sajedi-Amin S, Barzegar-Jalali M, Fathi-Azarbayjani A, et al. Solubilization of bosentan using ethanol as a pharmaceutical cosolvent. J Mol Liq. 2017;232:152–158.
- Bustamante P, Romero S, Peña A, et al. Enthalpy–entropy compensation for the solubility of drugs in solvent mixtures: paracetamol, acetanilide, and nalidixic acid in dioxane–water. J Pharm Sci. 1998;87:1590–1596.
- Delgado DR, Martínez F. Solubility and solution thermodynamics of some sulfonamides in 1-propanol + water mixtures. J Solution Chem. 2014;43:836–852.
- Jouyban A, Soltanpour S, Soltani S, et al. Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters. J Pharm Pharm Sci. 2007;10:294–308.
- Jouyban A. Handbook of solubility data for pharmaceuticals. Boca Raton (FL): CRC Press; 2010.